Iridex Stock Today
| IRIX Stock | USD 2.94 0.09 2.97% |
Performance5 of 100
| Odds Of DistressLess than 11
|
IRIDEX is trading at 2.94 as of the 24th of April 2024; that is -2.97 percent decrease since the beginning of the trading day. The stock's open price was 3.03. IRIDEX has less than a 11 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. Equity ratings for IRIDEX are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of March 2024 and ending today, the 24th of April 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 15th of February 1996 | Category Healthcare | Classification Health Care |
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California. The company has 16.25 M outstanding shares of which 319.52 K shares are currently shorted by private and institutional investors with about 7.39 trading days to cover. More on IRIDEX
Moving together with IRIDEX Stock
| 0.82 | NXL | Nexalin Technology | PairCorr |
Moving against IRIDEX Stock
| 0.69 | BJDX | Bluejay Diagnostics Financial Report 8th of May 2024 | PairCorr |
| 0.68 | NRC | National Research Corp | PairCorr |
| 0.66 | EFTR | Effector Therapeutics Financial Report 14th of May 2024 | PairCorr |
| 0.63 | CVS | CVS Health Corp Earnings Call This Week | PairCorr |
| 0.63 | HSTM | HealthStream | PairCorr |
| 0.62 | UNH | UnitedHealth Group Financial Report 12th of July 2024 | PairCorr |
| 0.56 | PRVA | Privia Health Group Financial Report 2nd of May 2024 | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 9th of May 2024
IRIDEX Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. IRIDEX's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding IRIDEX or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO President | David Bruce | ||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | ||||
| Average Analyst Recommendation Analysts covering IRIDEX report their recommendations after researching IRIDEX's financial statements, talking to executives and customers, or listening in on IRIDEX's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering IRIDEX. The IRIDEX consensus assessment is calculated by taking the average forecast from all of the analysts covering IRIDEX. | |||||
IRIDEX's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to IRIDEX's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand IRIDEX's financial leverage. It provides some insight into what part of IRIDEX's total assets is financed by creditors.
| |||||
IRIDEX (IRIX) is traded on NASDAQ Exchange in USA. It is located in 1212 Terra Bella Avenue, Mountain View, CA, United States, 94043 and employs 111 people. IRIDEX is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 49.25 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate IRIDEX's market, we take the total number of its shares issued and multiply it by IRIDEX's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. IRIDEX conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 16.25 M outstanding shares of which 319.52 K shares are currently shorted by private and institutional investors with about 7.39 trading days to cover.
IRIDEX currently holds about 17.97 M in cash with (6.75 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.12.
Check IRIDEX Probability Of Bankruptcy
Ownership AllocationIRIDEX has a total of 16.25 Million outstanding shares. IRIDEX secures noticeable amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check IRIDEX Ownership Details
IRIDEX Stock Price Odds Analysis
Based on a normal probability distribution, the odds of IRIDEX jumping above the current price in 90 days from now is about 27.19%. The IRIDEX probability density function shows the probability of IRIDEX stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 2.3115. This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, IRIDEX will likely underperform. Additionally, iRIDEX has an alpha of 0.0172, implying that it can generate a 0.0172 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of IRIDEX to move above the current price in 90 days from now is about 27.19 (This IRIDEX probability density function shows the probability of IRIDEX Stock to fall within a particular range of prices over 90 days) .
IRIDEX Stock Institutional Holders
Institutional Holdings refers to the ownership stake in IRIDEX that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of IRIDEX's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing IRIDEX's value.| Instituion | Recorded On | Shares | |
| Dimensional Fund Advisors, Inc. | 2023-12-31 | 48.3 K | |
| State Street Corporation | 2023-12-31 | 44.7 K | |
| Perkins Capital Management Inc | 2023-12-31 | 40.1 K | |
| Bank Of New York Mellon Corp | 2023-12-31 | 34.7 K | |
| Northern Trust Corp | 2023-12-31 | 28.4 K | |
| Wolverine Trading Llc | 2023-12-31 | 17.4 K | |
| Xtx Topco Ltd | 2023-12-31 | 14.7 K | |
| Hightower Advisors, Llc | 2023-12-31 | 10 K | |
| Ubs Group Ag | 2023-12-31 | 6.8 K | |
| Paragon Assoc & Paragon Assoc Ii Jv | 2023-12-31 | 1000 K | |
| Vanguard Group Inc | 2023-12-31 | 557.2 K |
IRIDEX Historical Income Statement
IRIDEX Income Statement is one of the three primary financial statements used for reporting IRIDEX's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of IRIDEX revenue and expense. IRIDEX Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, IRIDEX's Depreciation And Amortization is fairly stable compared to the past year. Interest Expense is likely to rise to about 1.7 M in 2024, whereas Total Revenue is likely to drop slightly above 40.7 M in 2024. View More FundamentalsIRIDEX Stock Against Markets
Picking the right benchmark for IRIDEX stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in IRIDEX stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for IRIDEX is critical whether you are bullish or bearish towards IRIDEX at a given time. Please also check how IRIDEX's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in IRIDEX without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Earnings Calls Now
Earnings CallsCheck upcoming earnings announcements updated hourly across public exchanges |
| All Next | Launch Module |
IRIDEX Corporate Directors
IRIDEX corporate directors refer to members of an IRIDEX board of directors. The board of directors generally takes responsibility for the IRIDEX's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of IRIDEX's board members must vote for the resolution. The IRIDEX board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Ann Rhoads | Director | Profile | |
| Robert Grove | Director | Profile | |
| Sanford Fitch | Independent Director | Profile | |
| Scott Shuda | Director | Profile |
How to buy IRIDEX Stock?
Before investing in IRIDEX, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in IRIDEX. To buy IRIDEX stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of IRIDEX. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase IRIDEX stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located IRIDEX stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased IRIDEX stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as IRIDEX, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy IRIDEX Stock please use our How to Invest in IRIDEX guide.
Already Invested in IRIDEX?
The danger of trading IRIDEX is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of IRIDEX is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than IRIDEX. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile IRIDEX is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether IRIDEX offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of IRIDEX's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Iridex Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Iridex Stock: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in IRIDEX. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy IRIDEX Stock please use our How to Invest in IRIDEX guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Complementary Tools for IRIDEX Stock analysis
When running IRIDEX's price analysis, check to measure IRIDEX's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IRIDEX is operating at the current time. Most of IRIDEX's value examination focuses on studying past and present price action to predict the probability of IRIDEX's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IRIDEX's price. Additionally, you may evaluate how the addition of IRIDEX to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
Is IRIDEX's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of IRIDEX. If investors know IRIDEX will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about IRIDEX listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.59) | Revenue Per Share 3.216 | Quarterly Revenue Growth (0.18) | Return On Assets (0.16) | Return On Equity (0.72) |
The market value of IRIDEX is measured differently than its book value, which is the value of IRIDEX that is recorded on the company's balance sheet. Investors also form their own opinion of IRIDEX's value that differs from its market value or its book value, called intrinsic value, which is IRIDEX's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IRIDEX's market value can be influenced by many factors that don't directly affect IRIDEX's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IRIDEX's value and its price as these two are different measures arrived at by different means. Investors typically determine if IRIDEX is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IRIDEX's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.